CirTran holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CirTran will likely underperform. Use CirTran value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on CirTran.
Risk-Adjusted Performance
Fair
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CirTran are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, CirTran showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow
108.1 K
Total Cashflows From Investing Activities
-3798.00
CirTran
CirTran Relative Risk vs. Return Landscape
If you would invest 1.50 in CirTran on September 28, 2025 and sell it today you would earn a total of 1.20 from holding CirTran or generate 80.0% return on investment over 90 days. CirTran is currently generating 1.9801% in daily expected returns and assumes 16.6194% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CirTran, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days CirTran is expected to generate 23.52 times more return on investment than the market. However, the company is 23.52 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.
CirTran Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CirTran's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CirTran, and traders can use it to determine the average amount a CirTran's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1191
Best Portfolio
Best Equity
Good Returns
Average Returns
CIRX
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average CirTran is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CirTran by adding it to a well-diversified portfolio.
CirTran Fundamentals Growth
CirTran Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CirTran, and CirTran fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CirTran Pink Sheet performance.
Evaluating CirTran's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CirTran has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CirTran has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company was incorporated in 1987 and is based in Las Vegas, Nevada. CIRTRAN CORP operates under Conglomerates classification in the United States and is traded on OTC Exchange. It employs 3 people.
Things to note about CirTran performance evaluation
Checking the ongoing alerts about CirTran for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CirTran help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
CirTran has some characteristics of a very speculative penny stock
CirTran appears to be risky and price may revert if volatility continues
CirTran currently holds 2.53 M in liabilities. CirTran has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CirTran until it has trouble settling it off, either with new capital or with free cash flow. So, CirTran's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CirTran sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CirTran to invest in growth at high rates of return. When we think about CirTran's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 2.92 M. Net Loss for the year was (838.47 K) with profit before overhead, payroll, taxes, and interest of 1.9 M.
Evaluating CirTran's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate CirTran's pink sheet performance include:
Analyzing CirTran's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CirTran's stock is overvalued or undervalued compared to its peers.
Examining CirTran's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating CirTran's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CirTran's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of CirTran's pink sheet. These opinions can provide insight into CirTran's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating CirTran's pink sheet performance is not an exact science, and many factors can impact CirTran's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for CirTran Pink Sheet Analysis
When running CirTran's price analysis, check to measure CirTran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CirTran is operating at the current time. Most of CirTran's value examination focuses on studying past and present price action to predict the probability of CirTran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CirTran's price. Additionally, you may evaluate how the addition of CirTran to your portfolios can decrease your overall portfolio volatility.